Interesting that Dr. Birge is in the booth and part of the Scientific Session. SITC'15 PPHM's Booth #121... NOTE: Join us for a Scientific Session - FRI Nov6 2015 7:30-9:00pm “The PS Signaling Pathway: A Promising Therapeutic Target Exploited by Tumors for Immune Evasion” PGM: * Raymond Birge (PhD, Rutgers) birgelab.org * Douglas Graham (MD, PhD, Emory) http://choa.org/Childrens-Hospital-Services/Cancer-and-Blood-Disorders/Meet-the-Team/Physicians-and-Researchers/Douglas-Graham * Dmitry Gabrilovich (MD, PhD, Wistar Inst.) http://www.wistar.org/our-science/scientists/dmitry-gabrilovich-md-phd * Rolf Brekken (PhD, UTSW/Dallas) http://www.utsouthwestern.edu/labs/brekken * Maria Karasarides (PhD, AstraZeneca - Sr. Director, ImmunoOncology, Global Medicines Dev.) http://www.linkedin.com/pub/maria-karasarides-ph-d/6/769/136